Literature DB >> 4586981

Thymus-dependent lymphocytes in tissue sections of rejecting rat renal allografts.

C M Balch, C B Wilson, S Lee, J D Feldman.   

Abstract

Lewis kidneys were grafted into BN recipients and examined at daily intervals up to 6 days after grafting with immunofluorescent reagents. A horse antiserum specific for T lymphocytes revealed an increasing number of T lymphocytes in the cellular infiltrates of rejecting allografts. These were detectable 1 day after grafting, reached a maximum 3 days later, and were relatively diminished at 6 days. In control isografts and nonimmunological inflammations of kidney, a small number of dispersed T lymphocytes was seen. A rabbit antirat thymocyte antiserum, given to allografted BN rats, prolonged survival of the grafts and decreased the cellular infiltrate and the number of T lymphocytes in the infiltrates. We conclude that in graft rejection there is a flow of T lymphocytes into areas of tissue damage and these T lymphocytes are immunologically reactive to graft antigens.

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4586981      PMCID: PMC2139462          DOI: 10.1084/jem.138.6.1584

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  10 in total

1.  Homing of specifically sensitized lymphocytes to allografts of skin.

Authors:  E M Lance; S Cooper
Journal:  Cell Immunol       Date:  1972-09       Impact factor: 4.868

2.  Proportion of T and B lymphocytes in lesions of Marek's disease: theoretical implications for pathogenesis.

Authors:  B T Rouse; R J Wells; N L Warner
Journal:  J Immunol       Date:  1973-02       Impact factor: 5.422

3.  The in vivo activity of in vitro immunized mouse thymocytes. II. Rejection of skin allografts and graft-vs-host activity.

Authors:  B T Rouse; H Wagner
Journal:  J Immunol       Date:  1972-12       Impact factor: 5.422

4.  Functional heterogeneity of murine lymphoid cells. II. Acquisition of mitogen responsiveness and of theta antigen during the ontogeny of thymocytes and "T" lymphocytes.

Authors:  J D Stobo; W E Paul
Journal:  Cell Immunol       Date:  1972-08       Impact factor: 4.868

5.  Functional heterogeneity of murine lymphoid cells. 3. Differential responsiveness of T cells to phytohemagglutinin and concanavalin A as a probe for T cell subsets.

Authors:  J D Stobo; W E Paul
Journal:  J Immunol       Date:  1973-02       Impact factor: 5.422

6.  Functional heterogeneity of murine lymphoid cells. IV. Allogeneic mixed lymphocyte reactivity and cytolytic activity as functions of distinct T cell subsets.

Authors:  J D Stobo; W E Paul; C S Henney
Journal:  J Immunol       Date:  1973-03       Impact factor: 5.422

7.  In vivo studies of the role of cytotoxic T cells in tumor allograft immunity.

Authors:  L R Freedman; J C Cerottini; K T Brunner
Journal:  J Immunol       Date:  1972-12       Impact factor: 5.422

8.  Thymus-derived cells in the early phase of delayed tuberculin reactions.

Authors:  R M Williams; B H Waksman
Journal:  J Immunol       Date:  1969-12       Impact factor: 5.422

9.  An improved technique of renal transplantation in the rat.

Authors:  S Lee
Journal:  Surgery       Date:  1967-05       Impact factor: 3.982

10.  Renal homotransplantation in rats. I. Allogeneic recipients.

Authors:  J D Feldman; S Lee
Journal:  J Exp Med       Date:  1967-11-01       Impact factor: 14.307

  10 in total
  3 in total

1.  Reassortment of lymphocytes in lymph from normal and allografted sheep.

Authors:  H R Miller; E P Adams
Journal:  Am J Pathol       Date:  1977-04       Impact factor: 4.307

2.  Effect of cyclosporine on distribution of macrophage subpopulations in rat hepatic allograft.

Authors:  Y Yamaguchi; M Misumi; K Mori; N Takata; M Goto; Y Makino; N Kikuchi; H Hamaguchi; N Hisama; M Takeya
Journal:  Dig Dis Sci       Date:  1993-04       Impact factor: 3.199

3.  T-cell migration into allografts.

Authors:  A K Bhan; C L Reinisch; R H Levey; R T McCluskey; S F Schlossman
Journal:  J Exp Med       Date:  1975-05-01       Impact factor: 14.307

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.